American College of Gastroenterology

Expanding therapeutic uses and regulatory concerns for GLP-1

41 clusters · 171 sources · last updated 2 days ago

Latest: Semaglutide improves liver markers in nonobese MASH patients

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

Health impacts of sedentary lifestyles and lifestyle habits

14 clusters · 97 sources · last updated 12 days ago

Latest: Sedentary lifestyle linked to increased colorectal cancer risk

Research continues to highlight the severe health risks associated with sedentary behavior. Studies indicate that prolonged sitting is linked to increased cancer mortality, specifically regarding obesity-related and type

Advancements in blood-based colorectal cancer detection

2 clusters · 4 sources · last updated 22 days ago

Latest: Blood-based protein biomarkers show promise for early colorectal cancer detection

Recent clinical data and research highlight advancements in blood-based screening methods for colorectal cancer (CRC). Clinical updates regarding the SimpleScreen CRC test show improved sensitivity for detecting advance

AbbVie IBD treatment clinical efficacy data

2 clusters · 5 sources · last updated 25 days ago

Latest: AbbVie reports clinical remission data for IBD treatments

AbbVie has presented new clinical data regarding the efficacy of its inflammatory bowel disease (IBD) treatments, specifically risankizumab (SKYRIZI) and upadacitinib (RINVOQ), for patients with Crohn’s disease and ulcer

Tegoprazan Phase 3 clinical trial results

2 clusters · 6 sources · last updated 25 days ago

Latest: Tegoprazan shows efficacy in Phase 3 NERD clinical trials

Clinical trial data for tegoprazan, an investigational potassium-competitive acid blocker (P-CAB), has shown positive results in treating non-erosive gastroesophageal reflux disease (NERD). Results from the Phase 3 TRI